Many insurance plans specifically exclude weight loss medications regardless of FDA approval
A 2024 paper in Science used optogenetics and human fMRI to identify GLP-1 receptor neurons in the dorsomedial hypothalamus as the substrate for the preingestive satiation these drugs produce the sense of fullness before you finish eating
[DOI] [PubMed] [Google Scholar] [15].Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR, A role for glucagon-like peptide-1 in the central regulation of feeding, Nature, 379 (1996) 6972
Its refreshing lemon flavor makes it a perfect, on-the-go
This mechanism not only aids in blood glucose control but also fosters a feeling of fullness, which can benefit overweight or obese patients by reducing calorie intake